Amrie Grammer
Fundador en AMPEL BioSolutions LLC .
Perfil
Amrie Grammer is the President, Chief Operating & Scientific Officer of AMPEL BioSolutions LLC, a company she founded in 2013.
She is currently the Director of Virginia Biotechnology Association.
Cargos activos de Amrie Grammer
Empresas | Cargo | Inicio |
---|---|---|
AMPEL BioSolutions LLC
AMPEL BioSolutions LLC BiotechnologyHealth Technology AMPEL BioSolutions LLC is a precision medicine company that develops and commercializes gene expression tests for blood or tissue samples. The private company is based in Charlottesville, VA, and has CRO capabilities. The company's tests provide clinical decision support by determining disease status, identifying molecular pathways, and predicting drug options. The company's technology is a cloud-based platform that hosts proprietary RNA analytic tools and machine learning algorithms. The company's precision medicine test portfolio covers various disease areas, including lupus, psoriasis, scleroderma, and lung cancer. The company was elected to the Coalition for 21st Century Precision Medicine in early 2022. AMPEL Biosolutions was founded in 2013 by Peter Lipsky and Amrie Grammer, and Peter Lipsky has been the CEO since then. | Fundador | 01/01/2013 |
Virginia Biotechnology Association
Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Virginia Biotechnology Association
Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | Commercial Services |
AMPEL BioSolutions LLC
AMPEL BioSolutions LLC BiotechnologyHealth Technology AMPEL BioSolutions LLC is a precision medicine company that develops and commercializes gene expression tests for blood or tissue samples. The private company is based in Charlottesville, VA, and has CRO capabilities. The company's tests provide clinical decision support by determining disease status, identifying molecular pathways, and predicting drug options. The company's technology is a cloud-based platform that hosts proprietary RNA analytic tools and machine learning algorithms. The company's precision medicine test portfolio covers various disease areas, including lupus, psoriasis, scleroderma, and lung cancer. The company was elected to the Coalition for 21st Century Precision Medicine in early 2022. AMPEL Biosolutions was founded in 2013 by Peter Lipsky and Amrie Grammer, and Peter Lipsky has been the CEO since then. | Health Technology |
- Bolsa de valores
- Insiders
- Amrie Grammer